Literature DB >> 20686267

Effect of particle size on skin permeation and retention of piroxicam in aqueous suspension.

Kunikazu Moribe1, Mizuho Shibata, Takayuki Furuishi, Kenjirou Higashi, Kazuo Tomono, Keiji Yamamoto.   

Abstract

The effects of particle size on the skin permeation and retention of piroxicam (PXC) in an aqueous suspension were investigated. PXC particles of about 23 nm, 173 nm, and 2.1 microm in size were prepared by the cogrinding of PXC/polyvinylpyrrolidone (PVP) K12/sodium dodecyl sulfate physical mixture (mean particle size, 9.6 microm) using a vibrational rod and ball mills. Particles were stable after storage in 0.1 m acetate buffer (pH 4.5) for 24 h. The amount of PXC that permeated and was retained in hairless mouse skin increased with the reduction of particle size up to 23 nm. Amorphous PXC was formed when PXC was coground with PVP, though the amorphous formation did not affect the amount of PXC permeated. Reduction of particle size to less than 50 nm, and the subsequent increase in surface area of PXC nanocrystals appeared to affect skin permeation and retention behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686267     DOI: 10.1248/cpb.58.1096

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Development, Characterization and Optimization of the Anti-Inflammatory Influence of Meloxicam Loaded into a Eucalyptus Oil-Based Nanoemulgel.

Authors:  Tamer M Shehata; Hanan M Elnahas; Heba S Elsewedy
Journal:  Gels       Date:  2022-04-22

2.  Antibacterial Activity of Fusidic Acid and Sodium Fusidate Nanoparticles Incorporated in Pine Oil Nanoemulgel.

Authors:  Ahmad M Eid; Ibraheem Istateyeh; Noura Salhi; Thaer Istateyeh
Journal:  Int J Nanomedicine       Date:  2019-12-02

3.  Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation.

Authors:  Malihe Shahbaziniaz; Seyed Mohsen Foroutan; Noushin Bolourchian
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.